Answers are grounded in this paper and cite their sources.
Objective: β-thalassemia is a lifelong blood disorder with anemia and systemic effects.One of the complications commonly encountered in β-thalassemia, particularly with advancing age, includes weakened bones.The roles of osteoprotegerin (OPG) and receptor activator for nuclear factor B ligand (RANKL) in age-related osteoporosis, as well as β-thalassemia-related bone disease, have been studied.This study aimed to compare the levels of OPG and RANKL in transfusion-dependent β-thalassemia (TDT) patients with healthy controls (HCs). Materials and Methods:This study comprised 120 TDT and 60 HCs, whose blood counts and biochemical profiles were assessed, followed by ELISA for OPG and RANKL according to the manufacturer's guidelines.Data were analysed using the Mann-Whitney U test and Spearman's correlation, with a p-value of ≤0.05 considered statistically significant.Results: The median age was slightly higher in HCs, with overall more male representation.Blood counts were comparable in both groups, except slightly higher WBC count.High serum ferritin, suggestive of iron overload, was noted in TDT.Findings suggest a reduced OPG and RANKL level in TDT patients compared to HCs.OPG was reduced in both male and female TDT patients, while RANKL was reduced in male TDT patients only.A very weak to no correlation of OPG or RANKL was determined with age and serum ferritin.Conclusion: Our results show reduced OPG and RANKL levels in TDT patients, particularly in males, with a very weak correlation with age and serum ferritin.However, further studies to explore their role in bone metabolism and association with bone density are needed.
No takes yet. Share an insight, caveat, or question.
Saddiq et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: